carfilzomib
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carflizomib | POWDER FOR INJECTION, INTRAVENOUS | 10 mg | ||||||||||||||
Carflizomib | POWDER FOR INJECTION, INTRAVENOUS | 30 mg | ||||||||||||||
Carflizomib | POWDER FOR INJECTION, INTRAVENOUS | 60 mg |
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Inpatient use of carfilzomib injection (Kyprolis) is restricted to patients who meet all of the following criteria:
Use for all other indications is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions